Skip to main content

Table 2 Mean dose (standard deviation) of target volumes and normal organs at risk—VMAT versus IMRT

From: Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy

Variables

IMRT (n = 74)

VMAT (n = 66)

P value

GTV, mean

7458 (85)

7457 (84)

0.93

PTV-H, mean

7369 (49)

7363 (47)

0.44

PTV-M, mean

6826 (214)

6788 (172)

0.26

PTV-L, mean

5694 (178)

5660 (74)

0.25

Brain stem, maximum

5108 (419)

5094 (387)

0.84

Spinal cord, maximum

4188 (225)

4095 (215)

0.02

Right eyeball, mean

821 (489)

877 (269)

0.42

Left eyeball, mean

805 (289)

902 (319)

0.08

RT optic nerve

4244 (951)

4574 (978)

0.11

Lt optic nerve

4416 (1070)

4657 (809)

0.21

Right parotid, mean

2970 (568)

2912 (383)

0.51

Left parotid, mean

3017 (482)

2949 (463)

0.48

Oral cavity, mean

3796 (479)

3713 (428)

0.32

Larynx, mean

3976 (516)

3919 (431)

0.52

Cervical esophagus, mean

3712 (420)

3836 (455)

0.19

  1. IMRT Intensity modulated radiotherapy, VMAT Volumetric modulated arc therapy, GTV Gross tumor volume, PTV-H High dose level of planning target volume, PTV-M Middle dose level of planning target volume, PTV-L Low dose level of planning target volume